- Home
- RLAY vs BOOT Comparison
RLAY vs BOOT Comparison
Compare RLAY & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | BOOT |
|---|---|---|
| Founded | 2015 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.5B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RLAY | BOOT |
|---|---|---|
| Price | $18.37 | $158.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 12 |
| Target Price | $19.50 | ★ $223.09 |
| AVG Volume (30 Days) | ★ 4.1M | 648.5K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | 25.00 |
| EPS | N/A | ★ 7.35 |
| Revenue | $15,355,000.00 | ★ $776,854,000.00 |
| Revenue This Year | N/A | $19.98 |
| Revenue Next Year | $324.03 | $13.91 |
| P/E Ratio | ★ N/A | $21.45 |
| Revenue Growth | ★ 53.44 | 14.59 |
| 52 Week Low | $3.03 | $133.18 |
| 52 Week High | $19.93 | $210.25 |
Technical Indicators
Market Signals| Indicator | RLAY | BOOT |
|---|---|---|
| Relative Strength Index (RSI) | 64.92 | 41.85 |
| Support Level | $6.67 | $135.35 |
| Resistance Level | N/A | $171.57 |
| Average True Range (ATR) | 1.03 | 8.11 |
| MACD | 0.21 | -1.83 |
| Stochastic Oscillator | 77.66 | 7.06 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.